EUVIMEDEUVIMED entdecken
Crossref

CT-based assessment of skeletal deterioration after high-dose denosumab discontinuation in metastatic breast cancer

Suguru Yokoo iD, Keisuke Uemura, Shinichiro Kubo, Masahiko Ikeda, Tetsumasa Yamashita, Kumiko Yoshikawa, Yoshito Otake iD, Chuji Terada iD

Breast Cancer · 19.11.2026

DOI: 10.1007/s12282-026-01943-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer, online erschienen am 19.11.2026. Verfasst von Suguru Yokoo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Fukuyama City Hospital, 5-23-1, Zaocho, Fukuyama, Hiroshima, Japan. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Japanese Orthopaedic Association, Japan Agency for Medical Research and Development, Cross-ministerial Strategic Innovation Promotion Program for the "Integrated Health Care System".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Bone metastasisBone mineral densityBreast cancerComputed tomographyDenosumab

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Fukuyama City Hospital, 5-23-1, Zaocho, Fukuyama, Hiroshima, Japan.
  • Department of Orthopaedic Medical Engineering, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan. surmountjp@gmail.com.
  • Department of Breast and Thyroid Surgery, Fukuyama City Hospital, 5-23-1, Zaocho, Fukuyama, Hiroshima, Japan.
  • Division of Information Science, Graduate School of Science and Technology, Nara Institute of Science and Technology, 8916-5, Takayamacho Ikoma, Nara, Japan.

ORCID-Profile: Suguru Yokoo, Yoshito Otake, Chuji Terada

Förderung

  • Japanese Orthopaedic Association
  • Japan Agency for Medical Research and Development
  • Cross-ministerial Strategic Innovation Promotion Program for the "Integrated Health Care System"
  • Cross-ministerial Strategic Innovation Promotion Program for the “Integrated Health Care System”

Zitieren

APA

Yokoo, S., Uemura, K., Kubo, S., Ikeda, M., Yamashita, T., Yoshikawa, K., Otake, Y., & Terada, C. (2026). CT-based assessment of skeletal deterioration after high-dose denosumab discontinuation in metastatic breast cancer. Breast Cancer. https://doi.org/10.1007/s12282-026-01943-3

Vancouver

Yokoo S, Uemura K, Kubo S, Ikeda M, Yamashita T, Yoshikawa K, et al. CT-based assessment of skeletal deterioration after high-dose denosumab discontinuation in metastatic breast cancer. Breast Cancer. 2026. doi:10.1007/s12282-026-01943-3

BibTeX
@article{Yokoo2026,
  author = {Yokoo, Suguru and Uemura, Keisuke and Kubo, Shinichiro and Ikeda, Masahiko and Yamashita, Tetsumasa and Yoshikawa, Kumiko and Otake, Yoshito and Terada, Chuji},
  title = {CT-based assessment of skeletal deterioration after high-dose denosumab discontinuation in metastatic breast cancer},
  journal = {Breast Cancer},
  year = {2026},
  doi = {10.1007/s12282-026-01943-3}
}
Kostenlos starten →